Bacteriophage therapy for management of bacterial infections in veterinary practice: what was once old is new again

References

• Abedon ST, Kuhl SJ, Blasdel BG, Kutter EM. Phage treatment of human infections. Bacteriophage 1, 66–85, 2011a doi: 10.4161/bact.1.2.15845
   PubMedGoogle Scholar
• Abedon ST, Thomas-Abedon C, Thomas A, Mazure H. Bacteriophage prehistory. Bacteriophage 1, 174–8, 2011b doi: 10.4161/bact.1.3.16591
   PubMedGoogle Scholar
• Allen RC, Pfrunder-Cardozo KR, Meinel D, Egli A, Hall AR. Associations among antibiotic and phage resistance phenotypes in natural and clinical Escherichia coli isolates. MBio 8, e01341-17, 2017 doi: 10.1128/mBio.01341-17
   PubMed Web of Science ®Google Scholar
• *Anonymous. Antimicrobial Resistance – Implications for New Zealanders. https://royalsociety.org.nz/assets/documents/Antimicrobial-resistance-factsheet-May-2017.pdf (accessed 14 June 2018). Royal Society – Te Apārangi, Wellington, NZ, 2017
   Google Scholar
• Biswas B, Adhya S, Washart P, Paul B, Trostel AN, Powell B, Carlton R, Merril CR. Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium. Infection and Immunity 70, 204–10, 2002 doi: 10.1128/IAI.70.1.204-210.2002
   PubMed Web of Science ®Google Scholar
• Brüssow H. Targeting the gut to protect the bladder: oral phage therapy approaches against urinary Escherichia coli infections? Environmental Microbiology 18, 2084–8, 2016 doi: 10.1111/1462-2920.13310
   PubMed Web of Science ®Google Scholar
• Burki T. Antibiotic development pipeline slows to a trickle. The Lancet Infectious Diseases 17, 1128–9, 2017 doi: 10.1016/S1473-3099(17)30586-8
   PubMed Web of Science ®Google Scholar
• Chan BK, Abedon ST, Loc-Carrillo C. Phage cocktails and the future of phage therapy. Future Microbiology 8, 769–83, 2013 doi: 10.2217/fmb.13.47
   PubMed Web of Science ®Google Scholar
• Chanishvili N. Phage therapy—history from Twort and d’Herelle through Soviet experience to current approaches. Advances in Virus Research 83, 3–40, 2012 doi: 10.1016/B978-0-12-394438-2.00001-3
   PubMed Web of Science ®Google Scholar
• Chen L-K, Kuo S-C, Chang K-C, Cheng C-C, Yu P-Y, Chang C-H, Chen T-Y, Tseng C-C. Clinical antibiotic-resistant Acinetobacter baumannii strains with higher susceptibility to environmental phages than antibiotic-sensitive strains. Scientific Reports 7, 6319, 2017 doi: 10.1038/s41598-017-06688-w
   PubMed Web of Science ®Google Scholar
• Cooper CJ, Denyer SP, Maillard J-Y. Stability and purity of a bacteriophage cocktail preparation for nebulizer delivery. Letters in Applied Microbiology 58, 118–22, 2014 doi: 10.1111/lam.12161
   PubMed Web of Science ®Google Scholar
• Endersen L, O’Mahony J, Hill C, Ross RP, McAuliffe O, Coffey A. Phage therapy in the food industry. Annual Review of Food Science and Technology 5, 327–49, 2014 doi: 10.1146/annurev-food-030713-092415
   PubMed Web of Science ®Google Scholar
• Fauconnier A. Regulating phage therapy: the biological master file concept could help to overcome regulatory challenge of personalized medicines. EMBO Reports 18, 198–200, 2017 doi: 10.15252/embr.201643250
   PubMed Web of Science ®Google Scholar
• Fauconnier A. Guidelines for bacteriophage product certification. Methods in Molecular Biology 1693, 253–68, 2018 doi: 10.1007/978-1-4939-7395-8_19
   PubMedGoogle Scholar
• Feiner R, Argov T, Rabinovich L, Sigal N, Borovok I, Herskovits AA. A new perspective on lysogeny: prophages as active regulatory switches of bacteria. Nature Reviews: Microbiology 13, 641–50, 2015
   PubMed Web of Science ®Google Scholar
• Fischer S, Kittler S, Klein G, Glünder G. Impact of a single phage and a phage cocktail application in broilers on reduction of Campylobacter jejuni and development of resistance. PloS One 8, e78543, 2013 doi: 10.1371/journal.pone.0078543
   PubMed Web of Science ®Google Scholar
• Fish R, Kutter E, Wheat G, Blasdel B, Kutateladze M, Kuhl S. Compassionate use of bacteriophage therapy for foot ulcer treatment as an effective step for moving toward clinical trials. Methods in Molecular Biology 1693, 159–70, 2018 doi: 10.1007/978-1-4939-7395-8_14
   PubMedGoogle Scholar
• Freitag T, Squires RA, Schmid J. Naturally occurring bacteriophages lyse a large proportion of canine and feline uropathogenic Escherichia coli isolates in vitro. Research in Veterinary Science 85, 1–7, 2008 doi: 10.1016/j.rvsc.2007.09.004
   PubMed Web of Science ®Google Scholar
• Galarce NE, Bravo JL, Robeson JP, Borie CF. Bacteriophage cocktail reduces Salmonella enterica serovar Enteritidis counts in raw and smoked salmon tissues. Revista Argentina de Microbiología 46, 333–7, 2014 doi: 10.1016/S0325-7541(14)70092-6
   PubMed Web of Science ®Google Scholar
• Golkar Z, Bagasra O, Pace DG. Bacteriophage therapy: a potential solution for the antibiotic resistance crisis. The Journal of Infection in Developing Countries 8, 129–36, 2014 doi: 10.3855/jidc.3573
   Google Scholar
• Grant A, Hashem F, Parveen S. Salmonella and Campylobacter: antimicrobial resistance and bacteriophage control in poultry. Food Microbiology 53, 104–9, 2016 doi: 10.1016/j.fm.2015.09.008
   PubMed Web of Science ®Google Scholar
• Greer GG. Bacteriophage control of foodborne bacteria. Journal of Food Protection 68, 1102–11, 2005 doi: 10.4315/0362-028X-68.5.1102
   PubMed Web of Science ®Google Scholar
• Hankin EH. The bactericidal action of the waters of the Jumna and Ganges rivers on Cholera microbes. Annales de l’Institut Pasteur 10, 511–23, 1896
   Google Scholar
• Hatfull GF. Dark matter of the biosphere: the amazing world of bacteriophage diversity. Journal of Virology 89, 8107–10, 2015 doi: 10.1128/JVI.01340-15
   PubMed Web of Science ®Google Scholar
• Hatfull GF, Hendrix RW. Bacteriophages and their genomes. Current Opinion in Virology 1, 298–303, 2011 doi: 10.1016/j.coviro.2011.06.009
   PubMed Web of Science ®Google Scholar
• Hawkins C, Harper D, Burch D, Änggård E, Soothill J. Topical treatment of Pseudomonas aeruginosa otitis of dogs with a bacteriophage mixture: a before/after clinical trial. Veterinary Microbiology 146, 309–13, 2010 doi: 10.1016/j.vetmic.2010.05.014
   PubMed Web of Science ®Google Scholar
• Heyse S, Hanna LF, Woolston J, Sulakvelidze A, Charbonneau D. Bacteriophage cocktail for biocontrol of Salmonella in dried pet food. Journal of Food Protection 78, 97–103, 2015 doi: 10.4315/0362-028X.JFP-14-041
   PubMed Web of Science ®Google Scholar
• Hobbs Z, Abedon ST. Diversity of phage infection types and associated terminology: the problem with “lytic or lysogenic”. FEMS Microbiology Letters 363, fnw047, 2016 doi: 10.1093/femsle/fnw047
   PubMed Web of Science ®Google Scholar
• Huys I, Pirnay J-P, Lavigne R, Jennes S, De Vos D, Casteels M, Verbeken G. Paving a regulatory pathway for phage therapy. Europe should muster the resources to financially, technically and legally support the introduction of phage therapy. EMBO Reports 14, 951–4, 2013 doi: 10.1038/embor.2013.163
   PubMed Web of Science ®Google Scholar
• Jensen KC, Hair BB, Wienclaw TM, Murdock MH, Hatch JB, Trent AT, White TD, Haskell KJ, Berges BK. Isolation and host range of bacteriophage with lytic activity against methicillin-resistant Staphylococcus aureus and potential use as a fomite decontaminant. PloS One 10, e0131714, 2015 doi: 10.1371/journal.pone.0131714
   PubMed Web of Science ®Google Scholar
• Kazi M, Annapure US. Bacteriophage biocontrol of foodborne pathogens. Journal of Food Science and Technology 53, 1355–62, 2016 doi: 10.1007/s13197-015-1996-8
   PubMed Web of Science ®Google Scholar
• Krut O, Bekeredjian-Ding I. Contribution of the immune response to phage therapy. The Journal of Immunology 200, 3037–44, 2018 doi: 10.4049/jimmunol.1701745
   PubMed Web of Science ®Google Scholar
• Lee JG, Sung YH, Baek IJ. Generation of genetically-engineered animals using engineered endonucleases. Archives of Pharmacal Research, 2018. doi: 10.1007/s12272-018-1037-z
   Web of Science ®Google Scholar
• Loc Carrillo C, Atterbury RJ, el-Shibiny A, Connerton PL, Dillon E, Scott A, Connerton IF. Bacteriophage therapy to reduce Campylobacter jejuni colonization of broiler chickens. Applied and Environmental Microbiology 71, 6554–63, 2005 doi: 10.1128/AEM.71.11.6554-6563.2005
   PubMed Web of Science ®Google Scholar
• Lu TK, Koeris MS. The next generation of bacteriophage therapy. Current Opinion in Microbiology 14, 524–31, 2011 doi: 10.1016/j.mib.2011.07.028
   PubMed Web of Science ®Google Scholar
• Mapes AC, Trautner BW, Liao KS, Ramig RF. Development of expanded host range phage active on biofilms of multi-drug resistant Pseudomonas aeruginosa. Bacteriophage 6, e1096995, 2016 doi: 10.1080/21597081.2015.1096995
   PubMedGoogle Scholar
• Marza JAS, Soothill JS, Boydell P, Collyns TA. Multiplication of therapeutically administered bacteriophages in Pseudomonas aeruginosa infected patients. Burns 32, 644–6, 2006 doi: 10.1016/j.burns.2006.02.012
   PubMed Web of Science ®Google Scholar
• Matsuda T, Freeman TA, Hilbert DW, Duff M, Fuortes M, Stapleton PP, Daly JM. Lysis-deficient bacteriophage therapy decreases endotoxin and inflammatory mediator release and improves survival in a murine peritonitis model. Surgery 137, 639–46, 2005 doi: 10.1016/j.surg.2005.02.012
   PubMed Web of Science ®Google Scholar
• Melo LDR, Veiga P, Cerca N, Kropinski AM, Almeida C, Azeredo J, Sillankorva S. Development of a phage cocktail to control Proteus mirabilis catheter-associated urinary tract infections. Frontiers in Microbiology 7, 1024, 2016 doi: 10.3389/fmicb.2016.01024
   PubMed Web of Science ®Google Scholar
• Merril CR, Biswas B, Carlton R, Jensen NC, Creed GJ, Zullo S, Adhya S. Long-circulating bacteriophage as antibacterial agents. Proceedings of the National Academy of Sciences 93, 3188–92, 1996 doi: 10.1073/pnas.93.8.3188
   PubMed Web of Science ®Google Scholar
• Miller-Ensminger T, Garretto A, Brenner J, Thomas-White K, Zambom A, Wolfe AJ, Putonti C. Bacteriophages of the urinary microbiome. Journal of Bacteriology 200, e00738-17, 2018 doi: 10.1128/JB.00738-17
   PubMed Web of Science ®Google Scholar
• Naylor NR, Atun R, Zhu N, Kulasabanathan K, Silva S, Chatterjee A, Knight GM, Robotham JV. Estimating the burden of antimicrobial resistance: a systematic literature review. Antimicrobial Resistance and Infection Control 7, 58, 2018 doi: 10.1186/s13756-018-0336-y
   PubMed Web of Science ®Google Scholar
• Nilsson AS. Phage therapy—constraints and possibilities. Upsala Journal of Medical Sciences 119, 192–8, 2014 doi: 10.3109/03009734.2014.902878
   PubMed Web of Science ®Google Scholar
• Payne RJ, Phil D, Jansen VA. Phage therapy: the peculiar kinetics of self-replicating pharmaceuticals. Clinical Pharmacology and Therapeutics 68, 225–30, 2000 doi: 10.1067/mcp.2000.109520
   PubMed Web of Science ®Google Scholar
• Pelfrene E, Willebrand E, Cavaleiro Sanches A, Sebris Z, Cavaleri M. Bacteriophage therapy: a regulatory perspective. Journal of Antimicrobial Chemotherapy 71, 2071–4, 2016 doi: 10.1093/jac/dkw083
   PubMed Web of Science ®Google Scholar
• Roach DR, Leung CY, Henry M, Morello E, Singh D, Di Santo JP, Weitz JS, Debarbieux L. Synergy between the host immune system and bacteriophage is essential for successful phage therapy against an acute respiratory pathogen. Cell Host and Microbe 22, 38–47.e4, 2017 doi: 10.1016/j.chom.2017.06.018
   PubMed Web of Science ®Google Scholar
• Salmond GPC, Fineran PC. A century of the phage: past, present and future. Nature Reviews: Microbiology 13, 777–86, 2015
   PubMed Web of Science ®Google Scholar
• Sarker SA, Sultana S, Reuteler G, Moine D, Descombes P, Charton F, Bourdin G, McCallin S, Ngom-Bru C, Neville T, et al. Oral phage therapy of acute bacterial diarrhea with two coliphage preparations: a randomized trial in children from Bangladesh. EBioMedicine 4, 124–37, 2016 doi: 10.1016/j.ebiom.2015.12.023
   PubMed Web of Science ®Google Scholar
• Schmerer M, Molineux IJ, Bull JJ. Synergy as a rationale for phage therapy using phage cocktails. PeerJ 2, e590, 2014 doi: 10.7717/peerj.590
   PubMed Web of Science ®Google Scholar
• Shivaswamy VC, Kalasuramath SB, Sadanand CK, Basavaraju AK, Ginnavaram V, Bille S, Ukken SS, Pushparaj UN. Ability of bacteriophage in resolving wound infection caused by multidrug-resistant Acinetobacter baumannii in uncontrolled diabetic rats. Microbial Drug Resistance 21, 171–7, 2015 doi: 10.1089/mdr.2014.0120
   PubMed Web of Science ®Google Scholar
• Smith HW, Huggins MB. Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics. Journal of General Microbiology 128, 307–18, 1982
   PubMedGoogle Scholar
• Smith HW, Huggins MB. Effectiveness of phages in treating experimental Escherichia coli diarrhoea in calves, piglets and lambs. Journal of General Microbiology 129, 2659–75, 1983
   PubMedGoogle Scholar
• Smith HW, Huggins MB, Shaw KM. Factors influencing the survival and multiplication of bacteriophages in calves and in their environment. Journal of General Microbiology 133, 1127–35, 1987a
   PubMedGoogle Scholar
• Smith HW, Huggins MB, Shaw KM. The control of experimental Escherichia coli diarrhoea in calves by means of bacteriophages. Journal of General Microbiology 133, 1111–26, 1987b
   PubMedGoogle Scholar
• Speck P, Smithyman A. Safety and efficacy of phage therapy via the intravenous route. FEMS Microbiology Letters 363, fnv242, 2016 doi: 10.1093/femsle/fnv242
   PubMed Web of Science ®Google Scholar
• *Squires RA, Johnstone T. Bacteriophage therapy: a ray of hope in the war against antimicrobial-resistant bacteria. Australian and New Zealand College of Veterinary Scientists, Dermatology Chapter, Science Week Proceedings. Pp 40–5, 2017
   Google Scholar
• Sulakvelidze A, Alavidze Z, Morris JG, Jr. Bacteriophage therapy. Antimicrobial Agents and Chemotherapy 45, 649–59, 2001 doi: 10.1128/AAC.45.3.649-659.2001
   PubMed Web of Science ®Google Scholar
• Summers WC. Bacteriophage therapy. Annual Review of Microbiology 55, 437–51, 2001 doi: 10.1146/annurev.micro.55.1.437
   PubMed Web of Science ®Google Scholar
• Summers WC. In the beginning. Bacteriophage 1, 50–1, 2011 doi: 10.4161/bact.1.1.14070
   PubMedGoogle Scholar
• Tsonos J, Oosterik LH, Tuntufye HN, Klumpp J, Butaye P, De Greve H, Hernalsteens J-P, Lavigne R, Goddeeris BM. A cocktail of in vitro efficient phages is not a guarantee for in vivo therapeutic results against avian colibacillosis. Veterinary Microbiology 171, 470–9, 2014 doi: 10.1016/j.vetmic.2013.10.021
   PubMed Web of Science ®Google Scholar
• Uppada V, Gokara M, Rasineni GK. Diagnosis and therapy with CRISPR advanced CRISPR based tools for point of care diagnostics and early therapies. Gene 656, 22–9, 2018 doi: 10.1016/j.gene.2018.02.066
   PubMed Web of Science ®Google Scholar
• Van Puyvelde S, Deborggraeve S, Jacobs J. Why the antibiotic resistance crisis requires a One Health approach. The Lancet Infectious Diseases 18, 132–4, 2018 doi: 10.1016/S1473-3099(17)30704-1
   PubMed Web of Science ®Google Scholar
• Verstappen KM, Tulinski P, Duim B, Fluit AC, Carney J, van Nes A, Wagenaar JA. The effectiveness of bacteriophages against methicillin-resistant Staphylococcus aureus ST398 nasal colonization in pigs. PloS One 11, e0160242, 2016 doi: 10.1371/journal.pone.0160242
   PubMed Web of Science ®Google Scholar
• Wittebole X, De Roock S, Opal SM. A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens. Virulence 5, 226–35, 2014 doi: 10.4161/viru.25991
   PubMed Web of Science ®Google Scholar
• Wommack KE, Colwell RR. Virioplankton: viruses in aquatic ecosystems. Microbiology and Molecular Biology Reviews 64, 69–114, 2000 doi: 10.1128/MMBR.64.1.69-114.2000
   PubMed Web of Science ®Google Scholar
• Wright A, Hawkins CH, Änggård EE, Harper DR. A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy. Clinical Otolaryngology 34, 349–57, 2009 doi: 10.1111/j.1749-4486.2009.01973.x
   PubMed Web of Science ®Google Scholar
• Yu L, Wang S, Guo Z, Liu H, Sun D, Yan G, Hu D, Du C, Feng X, Han W, et al. A guard-killer phage cocktail effectively lyses the host and inhibits the development of phage-resistant strains of Escherichia coli. Applied Microbiology and Biotechnology 102, 971–83, 2018 doi: 10.1007/s00253-017-8591-z
   PubMed Web of Science ®Google Scholar